Cargando…
Trends in Poliovirus Seroprevalence in Kano State, Northern Nigeria
BACKGROUND: Kano state has been a protracted reservoir of poliovirus in Nigeria. Immunity trends have been monitored through seroprevalence surveys since 2011. The survey in 2015 was, in addition, intended to assess the impact of use of inactivated poliovirus vaccine (IPV). METHODS: It was a health...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206109/ https://www.ncbi.nlm.nih.gov/pubmed/30376090 http://dx.doi.org/10.1093/cid/ciy637 |
_version_ | 1783366303473467392 |
---|---|
author | Verma, Harish Iliyasu, Zubairu Craig, Kehinde T Molodecky, Natalie A Urua, Utibeabasi Jibir, Binta Wudil Gwarzo, Garba Dayyabu Gajida, Auwalu U McDonald, Sharla Weldon, William C Oberste, M Steven Braka, Fiona Mkanda, Pascal Sutter, Roland W |
author_facet | Verma, Harish Iliyasu, Zubairu Craig, Kehinde T Molodecky, Natalie A Urua, Utibeabasi Jibir, Binta Wudil Gwarzo, Garba Dayyabu Gajida, Auwalu U McDonald, Sharla Weldon, William C Oberste, M Steven Braka, Fiona Mkanda, Pascal Sutter, Roland W |
author_sort | Verma, Harish |
collection | PubMed |
description | BACKGROUND: Kano state has been a protracted reservoir of poliovirus in Nigeria. Immunity trends have been monitored through seroprevalence surveys since 2011. The survey in 2015 was, in addition, intended to assess the impact of use of inactivated poliovirus vaccine (IPV). METHODS: It was a health facility based seroprevalence survey. Eligible children aged 6-9, 12-15 and 19-22 months of age brought to the paediatrics outpatient department of Murtala Mohammad Specialist Hospital between 19 October and 6 November 2015, were screened for eligibility. Eligible children were enrolled after parental consent, history taken, physical examination conducted, and a blood sample collected to test for neutralizing antibody titres against the three poliovirus serotypes. RESULTS: Overall, 365 results were available in the three age groups. In the 6-9-month-old age group, the seroprevalence was 73% (95% confidence interval [CI] 64-80%), 83% (95% CI 75-88%), and 66% (95% CI 57-73%) for serotypes 1, 2, and 3, respectively. In the 12-15- and 19-22-month-old age groups, seroprevalence was higher but still remained <90% across serotypes. Seroprevalence to serotypes 1 and 3 in 2015 was similar to 2014; however, for serotype 2 there was a significant improvement. IPV received in supplemental immunization activities was found to be a significant predictor of seropositivity among 6-9-month-old infants for serotypes 1 and 2. CONCLUSIONS: Seroprevalence for serotypes 1 and 3 remains low (<80%) in 6-9-month-olds. This poses a significant risk for poliovirus spread if reintroduced into the population. Efforts to strengthen immunization coverage are imperative to secure and sustain high population immunity. |
format | Online Article Text |
id | pubmed-6206109 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-62061092019-11-15 Trends in Poliovirus Seroprevalence in Kano State, Northern Nigeria Verma, Harish Iliyasu, Zubairu Craig, Kehinde T Molodecky, Natalie A Urua, Utibeabasi Jibir, Binta Wudil Gwarzo, Garba Dayyabu Gajida, Auwalu U McDonald, Sharla Weldon, William C Oberste, M Steven Braka, Fiona Mkanda, Pascal Sutter, Roland W Clin Infect Dis Supplement Articles BACKGROUND: Kano state has been a protracted reservoir of poliovirus in Nigeria. Immunity trends have been monitored through seroprevalence surveys since 2011. The survey in 2015 was, in addition, intended to assess the impact of use of inactivated poliovirus vaccine (IPV). METHODS: It was a health facility based seroprevalence survey. Eligible children aged 6-9, 12-15 and 19-22 months of age brought to the paediatrics outpatient department of Murtala Mohammad Specialist Hospital between 19 October and 6 November 2015, were screened for eligibility. Eligible children were enrolled after parental consent, history taken, physical examination conducted, and a blood sample collected to test for neutralizing antibody titres against the three poliovirus serotypes. RESULTS: Overall, 365 results were available in the three age groups. In the 6-9-month-old age group, the seroprevalence was 73% (95% confidence interval [CI] 64-80%), 83% (95% CI 75-88%), and 66% (95% CI 57-73%) for serotypes 1, 2, and 3, respectively. In the 12-15- and 19-22-month-old age groups, seroprevalence was higher but still remained <90% across serotypes. Seroprevalence to serotypes 1 and 3 in 2015 was similar to 2014; however, for serotype 2 there was a significant improvement. IPV received in supplemental immunization activities was found to be a significant predictor of seropositivity among 6-9-month-old infants for serotypes 1 and 2. CONCLUSIONS: Seroprevalence for serotypes 1 and 3 remains low (<80%) in 6-9-month-olds. This poses a significant risk for poliovirus spread if reintroduced into the population. Efforts to strengthen immunization coverage are imperative to secure and sustain high population immunity. Oxford University Press 2018-11-15 2018-10-30 /pmc/articles/PMC6206109/ /pubmed/30376090 http://dx.doi.org/10.1093/cid/ciy637 Text en © The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America. https://creativecommons.org/licenses/by/3.0/igo/ This is an Open Access article distributed under the terms of the Creative Commons Attribution 3.0 IGO (CC BY 3.0 IGO) License (https://creativecommons.org/licenses/by/3.0/igo/) which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Supplement Articles Verma, Harish Iliyasu, Zubairu Craig, Kehinde T Molodecky, Natalie A Urua, Utibeabasi Jibir, Binta Wudil Gwarzo, Garba Dayyabu Gajida, Auwalu U McDonald, Sharla Weldon, William C Oberste, M Steven Braka, Fiona Mkanda, Pascal Sutter, Roland W Trends in Poliovirus Seroprevalence in Kano State, Northern Nigeria |
title | Trends in Poliovirus Seroprevalence in Kano State, Northern Nigeria |
title_full | Trends in Poliovirus Seroprevalence in Kano State, Northern Nigeria |
title_fullStr | Trends in Poliovirus Seroprevalence in Kano State, Northern Nigeria |
title_full_unstemmed | Trends in Poliovirus Seroprevalence in Kano State, Northern Nigeria |
title_short | Trends in Poliovirus Seroprevalence in Kano State, Northern Nigeria |
title_sort | trends in poliovirus seroprevalence in kano state, northern nigeria |
topic | Supplement Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206109/ https://www.ncbi.nlm.nih.gov/pubmed/30376090 http://dx.doi.org/10.1093/cid/ciy637 |
work_keys_str_mv | AT vermaharish trendsinpoliovirusseroprevalenceinkanostatenorthernnigeria AT iliyasuzubairu trendsinpoliovirusseroprevalenceinkanostatenorthernnigeria AT craigkehindet trendsinpoliovirusseroprevalenceinkanostatenorthernnigeria AT molodeckynataliea trendsinpoliovirusseroprevalenceinkanostatenorthernnigeria AT uruautibeabasi trendsinpoliovirusseroprevalenceinkanostatenorthernnigeria AT jibirbintawudil trendsinpoliovirusseroprevalenceinkanostatenorthernnigeria AT gwarzogarbadayyabu trendsinpoliovirusseroprevalenceinkanostatenorthernnigeria AT gajidaauwaluu trendsinpoliovirusseroprevalenceinkanostatenorthernnigeria AT mcdonaldsharla trendsinpoliovirusseroprevalenceinkanostatenorthernnigeria AT weldonwilliamc trendsinpoliovirusseroprevalenceinkanostatenorthernnigeria AT oberstemsteven trendsinpoliovirusseroprevalenceinkanostatenorthernnigeria AT brakafiona trendsinpoliovirusseroprevalenceinkanostatenorthernnigeria AT mkandapascal trendsinpoliovirusseroprevalenceinkanostatenorthernnigeria AT sutterrolandw trendsinpoliovirusseroprevalenceinkanostatenorthernnigeria |